LOS ANGELES -- Surgeries to remove small tumors in stage IA non-small cell lung cancer (NSCLC) were associated with varying odds of long-term survival depending on the amount of lung removed, based on ...

For patients with stage IA non-small cell lung cancer (NSCLC), lung resections, including lobectomy and segmentectomy, are associated with improved long-term survival compared with wedge resection, ...

Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer The article by Grills ...

New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with improved long-term ...

Erin Gillaspie, MD, MPH, FACS, a faculty member of Vanderbilt University Medical Center’s (VUMC's) department of thoracic surgery, discussed trials that helped lung cancer surgeries evolve. Erin ...

For some patients with non-small cell lung cancer, removing part of the lobe rather than the entire lobe still provides benefit, study results show. Patients with stage 1A non-small cell lung cancer ...

A new meta-analysis provided high-quality evidence demonstrating that video-assisted thoracoscopic surgery (VATS) significantly reduces the risk for death by 21% compared with open lobectomy in ...

Individuals with chronic obstructive pulmonary disease (COPD) are already compromised, so the prospect of removing all or part of a lung is especially daunting for these patients if they are also ...